Peter Marks Usa vaccine Health reports Peter Marks Usa

News Scan for Jun 30, 2022

Reading now: 685
www.cidrap.umn.edu

FDA recommends booster update targets BA.4 and BA.5Following a vaccine advisory group input earlier this week, the Food and Drug Administration (FDA) today recommended that vaccine companies update their booster shots to target BA.4 and BA.5, two Omicron subvariants that are driving up cases in a number of countries.In a statement, Peter Marks, MD, PhD, who directs the FDA's Center for Biologics Evaluation and Research, urged vaccine makers to produce a bivalent booster adds in an Omicron BA.4/5 spike protein component.Vaccine makers have already been conducting clinical trials on boosters that have an Omicron BA.1 component.

The FDA urged the companies to submit data on those vaccines and to begin clinical trials on boosters modified with the Omicron BA.4/5 component.

Marks said the vaccine could potentially be used starting in early to mid-fall of 2022.In a related development, the US Department of Health and Human Services (HHS) yesterday announced an agreement to buy 105 million doses of Pfizer vaccine for fall vaccination campaigns, with an option to acquire up to 300 million doses.

The $3.2 billion contract includes both pediatric and adult doses and for the first time includes single-dose vials for some of the adult vaccine.Jun 30 FDA statement Jun 29 HHS statementStudy shows long-distance spread of COVID-19 in some indoor settingsA new systematic review of 18 studies finds evidence suggesting that long-distance airborne transmission (more than 2 meters away) of SARS-CoV-2 might occur in indoor settings such as restaurants, workplaces, and venues for choirs.

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA